A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT‐01

导出原文传递

翻译打印收藏纠错

作者： Vaibhav Sahai ^[1] ; Kent A. Griffith ^[2] ; Muhammad S. Beg ^[3] ; Walid L. Shaib ^[4] ; Devalingam Mahalingam ^[5] ; David B. Zhen ^[6] ; Dustin A. Deming ^[7] ; Mark M. Zalupski

作者单位： Division of Hematology and Oncology, Department of Internal Medicine,University of Michigan ^[1] Center for Cancer Biostatistics,University of Michigan School of Public Health ^[2] Division of Hematology and Oncology, Department of Internal Medicine,University of Texas ^[3] Department of Hematology and Oncology,Emory University ^[4] Division of Hematology and Oncology, Department of Medicine,Northwestern University ^[5] Division of Medical Oncology, Department of Internal Medicine,University of Washington ^[6] Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine,University of ^[7]

关键词 chemo immunotherapybiliary cancer cholangiocarcinoma immune checkpoint blockade immunotherapy

发布时间 2023-01-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交